Cargando…
P17-18. ANRS lipo5 sequences induce in vitro cross-reactive CD4+ T cell response against clade B and C
Autores principales: | Castelli, FA, Szely, N, Maillère, B |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767805/ http://dx.doi.org/10.1186/1742-4690-6-S3-P300 |
Ejemplares similares
-
A young patient with perinatal HIV infection treated for 17 consecutive years with antiretroviral therapy: extremely severe lipo-accumulation picture
por: Manfredi, Roberto
Publicado: (2010) -
OA04-01. Safety and immunogenicity of LIPO-5, a HIV-1 lipopeptide vaccine: results of ANRS VAC18, a phase 2, randomized, double-blind, placebo-controlled trial
por: Salmon-Céron, D, et al.
Publicado: (2009) -
P16-45. High avidity CD4+ T cell response directed to an immunodominant Gag epitope in HIV controllers: an ANRS EP36 study
por: Vingert, B, et al.
Publicado: (2009) -
Temporal trend of the first prescription of nevirapine: the ANRS CO3 Aquitaine Cohort, 1997-2008
por: Bruyand, M, et al.
Publicado: (2010) -
A new method for integrated analysis applied to gene expression and cytokines secretion in response to LIPO-5 vaccine in HIV-negative volunteers
por: Thiebaut, R, et al.
Publicado: (2012)